MedPath

Endari

These highlights do not include all the information needed to use ENDARI™ safely and effectively. See full prescribing information for ENDARI. ENDARI (L-glutamine oral powder ) Initial U.S. Approval: 2017

Approved
Approval ID

d5a783f4-12ef-4326-8faa-40018e45ba3b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 19, 2022

Manufacturers
FDA

Emmaus Medical, Inc.

DUNS: 784073434

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glutamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42457-420
Application NumberNDA208587
Product Classification
M
Marketing Category
C73594
G
Generic Name
Glutamine
Product Specifications
Route of AdministrationORAL
Effective DateOctober 27, 2020
FDA Product Classification

INGREDIENTS (1)

GlutamineActive
Quantity: 5 g in 1 1
Code: 0RH81L854J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Endari - FDA Drug Approval Details